Report Highlights
The global cannabis market should grow from $25.6 billion in 2019 to $77.6 billion by 2024 at a compound annual growth rate (CAGR) of 24.8% for the period of 2019-2024.
Report Includes
- 72 data tables and 17 additional tables
- A brief overview of the commercial potential of cannabis products, technologies and applications' markets
- Analyses of the global market trends in cannabis space, with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Information on cannabis cultivators, manufacturers and other market participants related to drug development industry, instrumentation, testing facilities and other market players
- Assessment on the role of government regulations, technological advancements, legalization of marijuana across several states, and the economic factors that affect the growth of the cannabis market
- A relevant patent analysis with data corresponding to cannabis related products and applications in drug discovery and development, recreational sector, supplemental products, and hemp related products
- Company profiles of leading market participants dealing in cannabis products within the drug development industry, including Aphria Inc., Aurora Cannabis Inc., C4 Laboratories, Canopy Growth Corp., and GW Pharmaceuticals
Report Scope
This report represents a current and important business tool to evaluate technologies, trends, products, and market participants in the cannabis sector. The geographic scope of this study covers the U. S. and companies worldwide. The report identifies the main elements of cannabis products and trends in different type of industries.
Analyst Credentials
Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology and industrial assay development and drug manufacturing. She has contributed to a number of scientific publications and holds several patents. She has expertise as an assay development scientist and is familiar with different research field trends and likely future developments.
Related Reports
Global e-cigarette Market
The report provides an overview of the global e-cigarette markets and analyzes market trends. Using 2022 as the base year, the report estimates market data for 2023 to 2028. The report covers the characteristics of the market, the leading e-cigarettes companies, various trends in end-user preferences and a range of geographic market opportunities.
Cannabis: The Medicinal Use
This report provides its readers with the history, components, and types of Cannabis. It gives a brief picture of how cannabis is affecting different parts of the body and its use in different medical conditions. Having strong components makes it useful for medical purposes, but not everyone can access it, so having alternative plants with similar strains mentioned in the report will help the readers explore more alternatives. However, strict rules on the consumption and sale of cannabis are illegal so this report covers the regulations that have to be followed in the top 10 countries for the buying and selling of cannabis for medical purposes.
Cannabis Extraction: Global Markets
The global cannabis extraction market should reach $3.7 billion by 2027 from $1.7 billion in 2022 at a compound annual growth rate (CAGR) of 16.1% for the forecast period of 2022 to 2027.
Cannabidiol (CBD) Oil: Global Markets
The global market for cannabidiol (CBD) oil should grow from $967.2 million in 2020 to $5.3 billion by 2025, at compound annual growth rate (CAGR) of 40.4% for the period of 2020-2025.
Recent Reports
Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets
The global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.
Rare Disease Diagnostics: Technologies and Global Markets
The global market for rare disease diagnostics is estimated to increase from $21.6 billion in 2024 to reach $34.7 billion by 2029, at a compound annual growth rate (CAGR) of 9.9% from 2024 through 2029.
Breakthrough Therapies: Market Dynamics and Investment Opportunities
The global market for breakthrough therapy drugs was valued at $133.3 billion in 2023. This market is expected to grow from $150.6 billion in 2024 to $287.5 billion by 2029, at a compound annual growth rate (CAGR) of 13.8% from 2024 to 2029.
Softgel Capsules: Global Markets
The global market for softgel capsules was valued at $7.4 billion in 2023. The market is expected to grow from $7.9 billion in 2024 to $11.5 billion by 2029, at a compound annual growth rate, or CAGR, of 7.7% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More